Commission Implementing Regulation (EU) 2021/2071 of 25 November 2021 subjecting certain vaccines and active substances used for the manufacture of such vaccines to export surveillance
Commission Implementing Regulation (EU) 2021/2071 of 25 November 2021 subjecting certain vaccines and active substances used for the manufacture of such vaccines to export surveillance
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
1. The following goods shall be subject to export surveillance for a period of 24 months from the date of entry into force of this Regulation:
(a)
vaccines against SARS-related coronaviruses (SARS-CoV species) currently falling under CN code 3002 20 10, irrespective of their packaging;
(b)
active substances, including master and working cell banks used for the manufacture of such vaccines, currently falling under CN codes ex 2933 99 80, ex 2934 99 90, ex 3002 90 90 and ex 3504 00 90.
2. For the purposes of this Regulation, ‘export’ means:
(a)
an export of Union goods under the export procedure within the meaning of Article 269(1) of Regulation (EU) No 952/2013;
(b)
a re-export of non-Union goods within the meaning of Article 270(1) of that Regulation after such goods have been subject to manufacturing operations including filling and packaging within the customs territory of the Union.
The export or re-export declaration of the goods mentioned in Article 1 shall, during the time referred to therein, include the TARIC additional codes mentioned in the Annex, or any corresponding future codes, and shall indicate the number of doses (in case of multi-dose containers, the number of doses for adults).
ANNEX
TARIC ADDITIONAL CODES
Manufacturer
Taric additional code for vaccines against SARS-related coronaviruses (SARS-CoV species)
Taric additional code for active substances ( *1 )
AstraZeneca AB
4500
4520
Pfizer / BioNTech
4501
4521
Moderna Switzerland / Moderna Inc
4502
4522
Janssen Pharmaceutica NV
4503
4523
CureVac AG
4504
4524
Sanofi Pasteur / GlaxoSmithKline Biologicals S.A
4505
4525
Novavax
4506
4526
Valneva
4507
4527
Gedeon Richter
4508
4528
Arcturus
4509
4529
PCI Pharma
4510
4530
Other manufacturers
4999
4999
Company
TARIC additional code for other substances ( *2 )
All manufacturers
4599
( *1 ) active substances including master and working cell banks used for the manufacture of vaccines against SARS-related coronaviruses (SARS-CoV species).
( *2 )
‘Other substances’ are products or substances that are not going to be used to manufacture vaccines against SARS-related coronaviruses (SARS-CoV species), but that are classified under the same CN codes as the active substances.
